AstraZeneca’s Covid troubles could see it pull out of making vaccines
AstraZeneca’s Covid troubles could see it pull out of making vaccines
AstraZeneca has suffered a series of setbacks with its Covid-19 jab and may exit the inoculation subsector altogether. Matthew Partridge reports
6 Aug 2021
AstraZeneca’s shareholders rebel over pay
AstraZeneca’s shareholders rebel over pay
Shareholders in AstraZeneca have rebelled over proposals to raise bonus levels for its bosses.
14 May 2021
AstraZeneca’s Pascal Soriot: in the crossfire of the vaccine wars
AstraZeneca’s Pascal Soriot: in the crossfire of the vaccine wars
AstraZeneca’s boss Pascal Soriot was winning plaudits for his stewardship when the Covid-19 pandemic struck. Since then, he’s been having a hard time …
27 Mar 2021
If you'd invested in: AstraZeneca and Mitie Group
If you'd invested in: AstraZeneca and Mitie Group
Pharmaceutical giant AstraZeneca is expected to grow its earnings, while outsourcer Mitie's share rice has been hit by a series of profit warnings.
10 Aug 2018
How to profit as Britain piles on the pounds
How to profit as Britain piles on the pounds
The world is getting fatter – and with no easy solution to obesity in sight, investing in healthcare providers and food and drink makers could bring b…
28 Sep 2017
A revolutionary new cancer treatment – and the blue-chip stock set to benefit
A revolutionary new cancer treatment – and the blue-chip stock set to benefit
A new kind of cancer therapy could make a big difference to survival rates - and transform the fortunes of one big UK drugs company. Matthew Partridge…
1 Aug 2014
The rise of ‘tax inversion’
The rise of ‘tax inversion’
More and more American businesses are snapping up companies in low-tax countries to make that their official home. British companies are in their sigh…
27 Jun 2014
Subscribe to MoneyWeek and get your first six issues FREE
Subscribe to MoneyWeek now and get your first six magazine issues absolutely FREE
AstraZeneca fight rumbles on
AstraZeneca fight rumbles on
The proposed takeover of AstraZeneca is proving to be one of the most controversial yet.
15 May 2014
How Ian Read launched a raid on Britain’s national champion
How Ian Read launched a raid on Britain’s national champion
As the head of US pharma giant Pfizer, Ian Read has led the takeover bid for Britain's AstraZeneca. But is the British-born boss driven by revenge?
14 May 2014
Company in the news: AstraZeneca
Company in the news: AstraZeneca
Drugs giant AstraZeneca is at the centre of a takeover tussle with US rival Pfizer. Phil Oakley looks at how the shares have been affected.
9 May 2014
Buy Big Pharma – the deal spree could be just beginning
Buy Big Pharma – the deal spree could be just beginning
With pharmaceutical stocks still looking cheap and some very smart deals being done, it’s a good time to buy in to the sector. John Stepek explains ho…
24 Apr 2014